ENOV ENOVIS CORPORATION

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

  • Canaccord Genuity Musculoskeletal Conference: Ben Berry, Chief Financial Officer, and Louie Vogt, Group President - Recon, will participate in a fireside chat on Monday, March 10th at 10:00 a.m. Pacific Time.
  • 37th Annual Roth Conference: Louie Vogt, Group President - Recon, will participate in a fireside chat on Monday, March 17th at 8:30 a.m. Pacific Time.
  • 24th Annual Needham Healthcarte Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, April 8th at 1:30 p.m. Eastern Time.

A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit .

Contact:

Kyle Rose

Vice President, Investor Relations

Enovis Corporation



EN
05/03/2025

Underlying

ENOVENOVIS CORPORATION

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ENOVIS CORPORATION

 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis Announces Appointment of Damien McDonald as Chief Executive Off...

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENOV), a leader in medical technology innovation, today announced the appointment of Damien McDonald as Chief Executive Officer, effective May 12, 2025. Mr. McDonald will also join the Enovis Board of Directors following the conclusion of the Company’s 2025 Annual Meeting of Stockholde...

April 2, 2025 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS...

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025 Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to exclusive events. WILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a global medical technology innovator, will feature its expanding portfolio of foot and ankle solutions at this year’s American College of Foot & Ankle Surgeons (ACFAS) Annual Scientific Conference in Phoenix, Ariz., taking plac...

March 25, 2025 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis to Participate in Upcoming Investor Conferences

Enovis to Participate in Upcoming Investor Conferences Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Canaccord Genuity Musculoskeletal Conference: Ben Berry, Chief Financial Officer, and Louie Vogt, Group President - Recon, will participate in a fireside chat on Monday, March 10th at 10:00 a.m. Pacific Time.37th Annual Roth Conference: Louie Vogt, Group President - Recon, will participate in a fi...

March 5, 2025 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis Announces Fourth Quarter and Full Year 2024 Results

Enovis Announces Fourth Quarter and Full Year 2024 Results Continued commercial momentum with fourth-quarter sales growth of 23% on a reported basis and strong adjusted EBITDA margin expansion Fourth-quarter Reconstructive sales grew 59% year-over-year on a reported basis and 10% on a Comparable Sales basis Exceeded year one commercial and integration plans for Lima Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth ...

February 26, 2025 1 EN
 PRESS RELEASE
Free
ENOV ENOVIS CORPORAT...

Enovis Announces Planned CEO Succession Process

Enovis Announces Planned CEO Succession Process Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has informed the Board of Directors (the “Board”) of his intention to retire from his position as Chief Executive Officer (CEO) of Enovis, effective upon his successor being appointed by the Board and assuming the position as CEO.  As part of the Company’s succession planning process, the Board is actively working with an executive search firm to identif...

February 26, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch